* If you want to update the article please login/register
The American Society of Anesthesiologists physical status I-III indicates that the study design and setting 44 patients undergoing arthroscopic knee surgery under general anesthesia, gender, age 18-65 years, as well as the American Society of Anesthesiologists physical status I-III. According to a computer-generated random number table, patients were randomly assigned to A group and B group. In addition, the investigators accompanied patients during preoperative visits with instructions on how to use the patient-controlled intravenous analgesia machine for pain control, as well as how to use the visual analog scale to measure pain at rest and while coughing. All the bispectral index values in the current study were maintained between 40 and 60 during surgery. When entering the operating room, patients were closely monitored by electrocardiogram, pulse oximetry, and non-invasive blood pressure. In addition, a radial artery catheter was used to performinvasive arterial pressure and blood gas monitoring. Sufentanil 0. 15 mg/kg, propofol 1-2 mg/kg, and rocuronium 0. 6 mg/kg were used intravenously to induce general anesthesia.
Source link: https://clinicaltrials.gov/ct2/show/NCT05533970
Pain management is a vital component of hip fracture patients' treatment. Patients with poorly controlled pain have an elevated risk of delirium, long-term functional impairment, and remain hospitalized longer. Today, fascia iliaca block is commonly used in the emergency department to relieve hip fracture pains, in comparison to other painkillers administered by vein or by mouth. This multicenter, randomized research is designed to determine the analgesic efficacy of PENG block versus fascia iliaca block, hypothesizing the superiority of the new approach over the gold standard.
Source link: https://clinicaltrials.gov/ct2/show/NCT05370586
Onabotulinumtoxin A has been shown in recent research as an effective pain reducer and help patients return to their previous level of functional fitness. Patients with plantar fasciitis are randomized for this new standard of care through corticosteroid injection into the plantar fascia and experimental therapy with BTX-A injection into the flexor digitorum brevis cohorts. When compared to those receiving corticosteroid, we expect that those who receive BTX-A injections will have improved outcomes on the Numeric Pain Rating Scale and the Foot and Ankle Ability Measure.
Source link: https://clinicaltrials.gov/ct2/show/NCT05367271
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions